341 related articles for article (PubMed ID: 23776095)
1. Association of antidepressant and atypical antipsychotic use with cardiovascular events and mortality in a veteran population.
Acharya T; Acharya S; Tringali S; Huang J
Pharmacotherapy; 2013 Oct; 33(10):1053-61. PubMed ID: 23776095
[TBL] [Abstract][Full Text] [Related]
2. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of atypical antipsychotics in depressive syndromes].
Quintin P; Thomas P
Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of antidepressants: selectivity or multiplicity?
Westenberg HG
J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
[TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of adherence measures and resource use in SSRI/SNRI-treated patients with depression using second-generation antipsychotics or L-methylfolate as adjunctive therapy.
Wade RL; Kindermann SL; Hou Q; Thase ME
J Manag Care Pharm; 2014 Jan; 20(1):76-85. PubMed ID: 24372461
[TBL] [Abstract][Full Text] [Related]
6. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
[TBL] [Abstract][Full Text] [Related]
7. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
8. Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting.
Seo HJ; Jung YE; Woo YS; Jun TY; Chae JH; Bahk WM
Hum Psychopharmacol; 2009 Mar; 24(2):135-43. PubMed ID: 19156709
[TBL] [Abstract][Full Text] [Related]
9. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database.
Coupland CA; Dhiman P; Barton G; Morriss R; Arthur A; Sach T; Hippisley-Cox J
Health Technol Assess; 2011 Aug; 15(28):1-202, iii-iv. PubMed ID: 21810375
[TBL] [Abstract][Full Text] [Related]
10. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
Edwards SJ; Hamilton V; Nherera L; Trevor N
Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine: a review of its use in major depression.
Holm KJ; Markham A
Drugs; 1999 Apr; 57(4):607-31. PubMed ID: 10235695
[TBL] [Abstract][Full Text] [Related]
12. SIADH with multiple antidepressants in a geriatric patient.
Blass DM; Pearson VE
J Clin Psychiatry; 2000 Jun; 61(6):448-9. PubMed ID: 10901346
[No Abstract] [Full Text] [Related]
13. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
Kent JM
Lancet; 2000 Mar; 355(9207):911-8. PubMed ID: 10752718
[TBL] [Abstract][Full Text] [Related]
14. The use of mirtazapine in difficult-to-treat patient populations.
Hirschfeld RM
Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S33-6. PubMed ID: 12404668
[TBL] [Abstract][Full Text] [Related]
15. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
[TBL] [Abstract][Full Text] [Related]
16. Mirtazapine is associated with less anxiolytic use among elderly depressed patients in long-term care facilities.
Gardner ME; Malone DC; Sey M; Babington MA
J Am Med Dir Assoc; 2004; 5(2):101-6. PubMed ID: 14984621
[TBL] [Abstract][Full Text] [Related]
17. Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT.
Kato M; Takekita Y; Koshikawa Y; Sakai S; Bandou H; Nishida K; Sunada N; Onohara A; Hatashita Y; Serretti A; Kinoshita T
J Psychiatr Res; 2017 Jun; 89():97-104. PubMed ID: 28213170
[TBL] [Abstract][Full Text] [Related]
18. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
Friedman ES; Davis LL; Zisook S; Wisniewski SR; Trivedi MH; Fava M; Rush AJ;
Eur Neuropsychopharmacol; 2012 Mar; 22(3):183-99. PubMed ID: 21920711
[TBL] [Abstract][Full Text] [Related]
19. Possible neurobiological mechanisms underlying faster onset of antidepressant action.
Blier P
J Clin Psychiatry; 2001; 62 Suppl 4():7-11; discussion 37-40. PubMed ID: 11229789
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
